Catalyst Wire Dossier Catalyst Wire Dossier

Pioglitazone/metformin hydrochloride combination tablets

pioglitazone/metformin · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pioglitazone/metformin hydrochloride combination tablets, covering 2016-11-22 to 2016-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes Mellitus

See pricing